Impact of None Pharmaceutical Interventions on COVID-19 in Nigeria, The Bayelsa Experience 2020

Background: Since the world experienced Covid-19 pandemic, about 1 million people are dead from about 31, 110, 400 confirmed infections and still counting with no vaccine pre-qualified for use worldwide. Most disturbing is the pre-symptomatic and oglio-symptomatic transmission if the virus, found in the upper respiratory tract. Best current attempts at controlling SARS-CoV-2 spread are focused on none pharmacuetical interventions that reduce rates of viral transmission. The Government of Nigeria on March 29th 2020, announced plans to initiate a national lockdown with various States to modify and implement the process. Method: The epidemiologic study utilise secondary data collated from inception of Covid-19 Emergency Operations Centre, (EOC) Incident Committee of Bayelsa State and analysed same for demographic qualities of structured age and sex of confirmed and probable cases. The case fatality across age groups and the effect on the lockdown on the epidemiologic curve was assessed. Exclusion criteria, was all incomplete data on the dashboard as at 8th October, 2020. Result: A total of 2193 suspects were tested which represent about 0.1 percent of the total population of the State, 53.5 % were female and 18.3 % tested positive of the suspects with 38.7 % as female. Case fatality for confirmed and probable cases was 4.2 % with age group greater than59 more at risk of death from Covid-19 even though more patients with milder disease were found among age groupless than40. A total of over 1, 722 deaths were prevented from about 41, 003 infections Conclusion: Risk of death from Covid-19 is reduced with youth. The epidemiologic curve demonstrated that cases and rate of transmission was reduced as the lockdown lasted. The lockdown mitigated and suppressed the spread if Covid-19 across the Local Government Areas of Bayelsa State. The Government ought to be applauded for this initiative, as several lives were saved